These results showed that CHRNA2, NPR3, VGLL3 and PAH are downregulated in tissue biopsies taken from primary PCa tumours of pN1 patients, suggesting that the four‐mRNA signature may have potential in the identification of pN1 PCa patients eligible for ePLND. This evidence concerns the gene PAH and posterior cortical atrophy.